VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $991 | +2.8% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $964 | +33.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $722 | -23.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $943 | -99.7% | 20,000 | +48.1% | 0.00% | +100.0% |
| Q3 2022 | $328,000 | +18.4% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $277,000 | -14.8% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $325,000 | +9.8% | 13,500 | +9.8% | 0.00% | 0.0% |
| Q4 2021 | $296,000 | -5.7% | 12,300 | +2.5% | 0.00% | 0.0% |
| Q3 2021 | $314,000 | +16.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $269,000 | +20.6% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $223,000 | -33.2% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $334,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
| Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
| Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
| Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
| Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
| RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
| Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
| TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |